{{Rsnum
|rsid=63750540
|Chromosome=3
|Orientation=plus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=MLH1
|position=37025979
|Gene_s=MLH1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ClinVar
|rsid=63750540
|Reversed=0
|FwdREF=A
|FwdALT=T
|REF=A
|ALT=T
|RSPOS=37067470
|CHROM=3
|dbSNPBuildID=136
|SSR=0
|SAO=1
|VP=0x050068000000000002100100
|GENEINFO=MLH1:4292
|GENE_NAME=MLH1
|GENE_ID=4292
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000003.11:g.37067470A>T
|CLNSRC=InSiGHT
|CLNORIGIN=1
|CLNSIG=5
|CLNDBN=Lynch syndrome
|Disease=Lynch syndrome
|Tags=PM;PMC;OTHERKG;LSD
|CLNACC=RCV000030213.2
|CLNDSDB=GeneReviews:MedGen:SNOMED_CT
|CLNDSDBID=NBK1211:C0009405:315058005
|CLNSRCID=c.1381A>T
}}

{{PMID Auto
|PMID=19116
|Title=A potent new beta2-adrenoceptor blocking agent.
|OA=1
}}

{{PMID Auto
|PMID=10422993
|Title=Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.
}}

{{PMID Auto
|PMID=11585727
|Title=A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families.
}}

{{PMID Auto
|PMID=12658575
|Title=Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
|OA=1
}}

{{PMID Auto
|PMID=15173238
|Title=Site directed mutagenesis of hMLH1 exonic splicing enhancers does not correlate with splicing disruption.
|OA=1
}}

{{PMID Auto
|PMID=18561205
|Title=A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}